Indonesia greenlights use of AstraZeneca Covid-19 vaccine; total cases now stands above 1.455 million


Young girls practice ballet dance in a class wearing protective face masks as protocols and precautions to avoid the Covid-19 coronavirus infection at the Namarina ballet school in Jakarta on March 19, 2021. - AFP

JAKARTA, March 20 (dpa): Indonesia can start using 1.1 million doses of the vaccine developed by AstraZeneca, after its distribution in the country was delayed because of concerns about blood clot cases in Europe, the country's drug agency has announced.

"The benefits of giving the AstraZeneca Covid-19 vaccine outweigh the risk, so that the AstraZeneca Covid-19 vaccine can be used," the Food and Drug Control Agency said on its website.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Visitors at China theme park hang upside down as ride stalls over May Day holiday
No truth to claims Israeli ship docked at Port Klang, says Anwar
Malaysian mission in Jakarta hosts 'Flavours of Malaysia' to promote cultural exchange
Malaysian King gets warm welcome at Singapore Parliament; the first king of Malaysia to visit House
Asia shares rise on rate cut bets; Aussie slips on RBA
Amazon to spend nearly US$9bil to expand cloud infra in Singapore
FBM KLCI pushes past 1,600
Thai gateway to adventure for Malaysian cyclists just across the Kelantan border
KKB Polls: Only election offence so far was man displaying King's image, says EC
Apple working on AI chips for data centers, WSJ reports

Others Also Read